Blue Cross and Blue Shield Companies Cover COVID-19 Testing and Treatment

Published April 16, 2020

Making healthcare affordable. For the Health of America.

The number one priority for Blue Cross Blue Shield (BCBS) companies—especially as the nation faces this unprecedented health crisis—is getting their members across the country the care they need.

Through May 31, all BCBS companies—including the BCBS Federal Employee Program® (FEP®)—are: 

  • Waiving cost-sharing for COVID-19 testing and treatment. That means members will pay nothing out-of-pocket to take care of their COVID-19-related health needs.
  • Waiving all prior authorization requirements for COVID-19 testing and related covered services.
  • Increasing access to prescription medications.

“It is important that our members feel safe and secure during these unprecedented times,” said Scott P. Serota, current president and CEO of the Blue Cross Blue Shield Association. “That’s why we are committed to ensuring our members who are dealing with a diagnosis of COVID-19 can easily access the care they need.”

For full details on benefits, services and network coverage—which may vary by health plan—find each BCBS company’s statement below:

The Blue Cross and Blue Shield Association is a national federation of 36 independent, community-based and locally operated Blue Cross and Blue Shield companies that collectively provide health care coverage for one in three Americans.

The Blue Cross Blue Shield Association is an association of 35 independent, locally operated Blue Cross and/or Blue Shield companies.